chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After leaving clinic and returning to car, experienced pain in neck radiating across and down back and both arms. She stated that she "couldn't move which lasted for about 20 minutes as extreme (husband wanted to take her to the hospital but she decided to go home) and then on an off after. Did subside after a couple of hours, but had extreme headache and fever of 99.6. Headache lasted all night; took TYLENOL PM every few hours, and woke up still with a dull ache. "Husband called health district on 10/27/17 at ask whether we had heard of reactions such as this, which we have not. Explained that a VAERS report would be filed. Called patient on 10/30 for additional information. Feeling fine at the time of interview.
pt recvd vax; devel fever greater than 102 w/in 26 hrs of vax; fever resolved w/in 24 hrs; md expressed a concern w/ the particular lot of the vax
Arm was sore after receiving flu shot for a prolonged amount of time initially felt burning 3 weeks following. Arm was painful and hard to lift.
She got her vaccine, within 5 minutes she felt a headache coming on.  Within an hour it was much worse, and then as the evening progressed within 2-3 hours it was severe.  Her arm is also sore and she feels shaky and not well.  She took some Tylenol PM last night and they did not work, and she just took some Excedrin migraine for the pain as well . The headache is not getting any better, just feels like something is sitting on her head.
Pain and swelling at injection site; Pain and swelling at injection site; Scratchy throat; Runny nose; Coughing; Sneezing; Postnatal drip; This is a spontaneous report from a contactable consumer (patient herself). A 45-years-old non pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration, administered in left arm on 03Feb2021 at 09:00 (age at vaccination: 45 years) as a single dose for COVID-19 immunization. The patients medical history and concomitant medications were not reported. The patient did not receive any other vaccine in 4 weeks. The patient was vaccinated in pharmacy or drug store. On 04Feb2021 13:00, the patient experienced pain and swelling at injection site, scratchy throat, runny nose, coughing, sneezing, postnatal drip. On 04Feb2021, the patient underwent sars-cov-2 test results were pending. The patient did not receive any treatment for the events. The patient did not get COVID prior to vaccination. The patient was tested for COVID post vaccination for which the results are pending. The outcome of all the events was recovering.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
3/05- shot given. 3/06- arm swelled to size of tennis ball at site.  3/07 itching, discomfort.  3/08 Broke out on torso with welts, rapid heart rate, discomfort, nothing 09-started feeling better, some spots dissipating, itch gone.
devel t103 x  2hrs p/vax 29DEC94; APAP immed p/vax; pt was very irritable-APAP alcohol baths failed to dec temp; taken to ER 30DEC94; fussy & didn't eat normally in 1JAN95; dec activity & rapid breathing; copious salivation, throat sl red
major swelling of lymph glands in neck jaw/continue to have minor swelling of one lymph gland on my left clavicle; patient had a maximum temperature of 101; This is a spontaneous report from a contactable Other Healthcare Professional (nurse). A 46-years-old non-pregnant female patient reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: ER9231), via an intramuscular route of administration, administered in left arm on 06Jan2021 08:00 (at the time of 46-year-old) at single dose for COVID-19 immunization. The patient medical history included known allergies: shellfish. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medication within 2 weeks. Facility type vaccine was Hospital. Prior to vaccination, the patient had not Covid. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received the first dose of bnt162b2 (COVID-19), on an unspecified date for COVID-19 immunization. On 07Jan2021 07:00 after the second dose vaccination, the patient experienced major swelling of lymph glands in neck jaw/continue to have minor swelling of one lymph gland on my left clavicle patient had a maximum temperature of 101. It was reported that the first week patient had a maximum temperature of 101 and major swelling of lymph glands in neck jaw. Patient continue to have minor swelling of one lymph gland on my left clavicle 8 weeks post second vaccine. The patient underwent lab tests and procedures which included body temperature increased: 101 (the first week I had a max temp of 101) on 07Jan2021. The patient did not received any treatment for events. The outcome of events was resolved with sequel.  No follow-up attempts are possible. No further information is expected.
Subject was enrolled in Vaccine Trial and received 3 doses of CERVARIX. Following closeout from CVT in 12/17/2010, patient continued in Extended Follow-up Study (since 8/1/2011). At study visit on 6/21/2013, parents-in-law of patient reported she passed away at home on 9/25/2012. Patient has hx of severe dilated cardiomyopathy starting in 2008, and suffered severe respiratory illnesses and a stroke in 2010 and 2011, respectively. Cause of death was believed to be related to her underlying heart condition and not related to vaccination.
Sneezing; Congested all last night; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING and NASAL CONGESTION in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced NASAL CONGESTION. On an unknown date, the patient experienced SNEEZING. At the time of the report, SNEEZING and NASAL CONGESTION outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.
Pt experienced flushing. Patient waited 30 min then we took BP -> 175/90. Pt say his BP runs high as I talked to him he started feeling better. I called him at home 1 1/2 hr later & he was ok.
Some problem with my arm; that is red; This is a spontaneous report from a non-contactable consumer (patient)  This patient of an unknown age and gender received  BNT162B2 (Pfizer-BioNTech COVID-19 at a single dose for COVID-19 immunization.Medical isotry and concomitant medication were not provided.The patient stated as follows:I have some problem with my arm that is red .The patient was wondering if it was an allergic reaction.The  outcome of the event was unknown at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
suspected vaccination failure/had the shot and had a mild case of shingles.; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received Shingles vaccine and experienced mild case of shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.
pt recvd vax in 1984 & 4 days following post-trauma splenectomy exp marked swelling of the arm & t102 w/in 24 hrs p/vax;
Information has been received from the authors in a published literature article concerning an a 22-year-old previously healthy female experienced a sudden onset of diarrhea, nausea and weight loss approximately 2 months after receiving the third GARDASIL. A thorough gastrointestinal diagnostic workup failed to reveal any underlying etiology, and the patient was diagnosed with irritable bowel syndrome. In addition to persistent gastrointestinal symptoms, the patient also developed lightheadedness, dizziness, pre-syncope and episodic tachycardia. A tilt table test revealed a rise in heart rate from 90 bpm supine to 134 bpm standing within 1 min of tilt. At the twentieth minute of tilt, the patient experienced a drop in blood pressure to 88/43 accompanied by symptoms of pre-syncope. The tilt table test was consistent with Postural orthostatic tachycardia syndrome (POTS) and neurocardiogenic syncope (NCS). Further autonomic testing revealed normal heart rate variability and Valsalva response, and quantitative sudomotor test showed mild reduction in the distal leg suggestive of a small fiber neuropathy. In addition to an increased fluid/salt intake, the patient was treated with midodrine for vasoconstriction and fludrocortisone for volume expansion, and her symptoms have gradually improved over the course of 2 years. The reporter stated that nevertheless, none of the patients experienced complete resolution of symptoms, and all patients continued to experience some residual symptoms. Possible pathogenesis of the new onset POTS after vaccination may include the mechanism of molecular mimicry, whereas HPV vaccine epitopes may induce formation of cross-reacting antibodies against potential targets of the autonomic ganglia, neurons, cardiac proteins or 31/2-adrenergic and M2/3 muscarinic receptors. Additionally, induction of bystander lymphocyte lymphocyte activation and a broad spectrum of cytokine responses elicited by the HPV vaccine may also be involved. The reporter stated that the temporal association between vaccination with GARDASIL and the onset of symptoms of POTS in healthy young women is significant and deserves further investigation for assessment of a possible casual relationship. The reporter stated that other related conditions, such as small fiber neuropathy, autonomic neuropathy, complex regional pain syndrome and fibromyalgia have been reported after immunization with various vaccines, including GARDASIL. This is one of several reports from the same literature article: 1310USA000643, 1007USA02012, 1310USA003813, 1310USA003799. 1310USA003819. Additional information has been requested.
Headaches for mostly left side of the head and the same intensity for 5 days straight mostly comes back at night when the effect of the tylenol is gone
Pt came to pharmacy and presented a medical report from an urgent care where pt complaint was penile and testicular swelling as well as an abscess in that area. Pt states had been experiencing the swelling and then the abscess for around  week's time and received the moderna vaccine on 12/5 and states he thinks it's possible this adverse event was from the vaccine.
This spontaneous report as received from a certified medical assistant refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates the patients were vaccinated with improperly stored ROTATEQ, orally, lot # L03551, expiry date 21-MAY-2017, lot # K022993, expiry date 20-JUL-2016 and lot # L029618, expiry date 20-MAY-2017 (dose and site of administration were not reported. The vaccines experienced temperature excursion of maximum temperature of 22.7 degrees Celsius for 3 hours and 48 minutes and minimum temperature of 0.2 degrees Celsius for 31 hours 1 minute. This is one of several reports received from the same reporter. Additional information has been requested.
The day of the vaccination March 6, 2021, I had just a sore arm.  The tenderness lasted about 36 hours. A week later beginning the evening of March 13, 2021, my arm at the injection shot swelled to the circumference size of a tennis ball.  The swollen area was very red, very warm, had hives and itched.  The reaction has mostly subsided as of this date March 18, 2021. In the interval between March 6 and 13 I had other small patches of itchy rash across my shoulders and lower back that scabbed as they cleared up.
Flu like symptoms after first booster; stayed in bed for one and a half days.; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 014M20A and 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Lumbar disc disease (spinal problem (Spaces between L3 and L4).).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.). On 17-Nov-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.) had resolved.            It was reported that he receives Steroid injections from time to time for long time medical condition with his spine in the lumbar region.The shots did not make his pre-existing spinal problem worse. After the first dose, he did not have any side effects. Patient does not recall if any side effects after second dose.  No treatment medications were reported.   This case was linked to MOD-2022-553180 (Patient Link).
Pt. got ZOSTAVAX on Friday 8-11-17 and develops shingles-like rash on abdomen.
Left jaw visible swelling, and perceived left side of tongue and left side of throat "felt swollen"; this occurred at 2 am, 17 hours post vaccination, and again a week later at 11 pm at night; both times symptoms did not impared breathing or swallowing and resolved after taking Benadryl, sipping water, and gargling with salt water
Excruciating left hip pain; This is a spontaneous report from a contactable Nurse (patient).   A 44-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9263, Expiry date: Unknown) via an unspecified route of administration, administered in Arm Right on 25Feb2021 at 16:00 (age at vaccination: 44years-old) as dose 1, single for COVID-19 immunization. The patient had no medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior and received other unspecified medications 2 weeks prior to the COVID vaccine. Patient had no known allergies. The patient was not tested positive for covid-19 prior to vaccination and had not been tested post vaccination. On 27Feb2021 at 03:00 AM patient experienced excruciating left hip pain. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
My son woke up Friday morning super hot he went to school got sent home from school I gave him Tylenol when he got home he was running a fever 103. His arm all the way down from the injection site was a huge hive rash all over and is still present. He came out of his room from laying down at about 8:00 pm saying his heart was racing he was turning blue lips pale as a ghost super clammy and I put my Apple Watch on him his heart rate was 176BPM  he complained his chest was hurting and that he was having a hard time breathing. I called the advice nurse at Vancouver clinic she advised me to give him a Benadryl and Tylenol she said that she believe this was an allergic reaction to the shot & that I need to get his heart rate down she would call me back in 20 mins and if it wasn?t below 120 to call 911  when she called me back it got down to 120  he said his chest wasn?t hurting to much anymore and she told me give him one more benadryl and to watch him making sure to give him Tylenol every six- eight hours. I took him in Saturday to urgent care because he still had the hives rash the urgent care dr did ekg chest X-ray on him for his heart and scheduled a follow up with his primary this Friday. He told me that he believed it was an allergic reaction also the vaccine and to watch him
Patient starting feeling weak the next day after immunization and reports passing out while working in her garden. She was feeling some better after 4 days, but still reports feeling a little more weak than normal.
had it twice; pain; itching; burning; feeling bad; Patient not received 2nd dose yet; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles (Verbatim: had it twice), pain (Verbatim: pain), pruritus (Verbatim: itching), burning sensation (Verbatim: burning), feeling bad (Verbatim: feeling bad) and incomplete course of vaccination (Verbatim: Patient not received 2nd dose yet). The outcome of the shingles, pain, pruritus, burning sensation and feeling bad were not reported and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles, pain, pruritus, burning sensation and feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the shingles, pain, pruritus, burning sensation and feeling bad to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 21-JUL-2023 This case was reported by patient via interactive digital media The patient stated that he/she had it twice and he/she hope did not get it again.  He/she took the medicine the doctor ordered and it came back. It's terrible, the pain, the burning, the itching and how bad it felt.  The patient had already been vaccinated once and he/she missing the other vaccine and he/she hope they get vaccinated and do not delay in getting it. Till the time of reporting the patient had not received the second dose of Shingles vaccine, which led to incomplete course of vaccination. Follow up was not possible, as no contact details were available.
PENTACEL reconstituted with sterile water with no reported adverse event; Initial information was received on 15-Nov-2021 regarding an unsolicited valid non-serious case received from other health professional and non-healthcare professional via Medical information (MI) under reference number - 00858573)  This case involves a 4-months old female patient who was vaccinated with suspect vaccine DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE [PENTACEL (VERO)] while preparing vaccine reconstituted with sterile water with no adverse event (product preparation error).  The patient's past medical treatments, concomitant medication and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for prophylactic vaccination.  On 15-Nov-2021, the patient received a 0.5ml {total} dose of suspect DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE [PENTACEL (VERO)] (lot number UJ531AAA and expiry date 22-Jul-2022 was reported) via intramuscular route in the left thigh for prophylactic vaccination.  It was a case of an actual medication error due to wrong solution used in drug reconstitution (latency was on same day).  At the time of report, no adverse event reported.  Event outcome was unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
STOMACH PAIN; CHILLS; FEVER; FATIGUE; HEART RATE INCREASED; DIZZINESS; TINGLING FEELING AT THE SITE OF INJECTION RADIATING UP TOWARD NECK; COLD; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-MAR-2021 19:15 at left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced cold. On 08-MAR-2021, the subject experienced tingling feeling at the site of injection radiating up toward neck. On 09-MAR-2021, the subject experienced heart rate increased. On 09-MAR-2021, the subject experienced dizziness. On 09-MAR-2021, the subject experienced fatigue. Treatment medications included: ibuprofen. On 09-MAR-2021 01:00, the subject experienced chills. On 09-MAR-2021 01:00, the subject experienced fever. On 09-MAR-2021 04:55, Laboratory data included: Body temperature (NR: not provided) 101.3 F, and Heart rate (NR: not provided) 140 BPM. On 11-MAR-2021, the subject experienced stomach pain. Laboratory data included: Body temperature (NR: not provided) 101.4 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart rate increased, stomach pain, cold, dizziness, tingling feeling at the site of injection radiating up toward neck, chills, and fever on MAR-2021, and fatigue. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
The pt experienced nausea and vomiting, shortness of breath, wheezing, elevated blood pressure. The injection site appeared red, inflamed, raised. The pt was given Benadryl.
fever of 101.7, cold, then sweat, resulting in a seizure affecting speech and vision all gray.  Ambulance to Hospital.
Severe muscle pain and weakness. Feeling hot episodes come & go, paleness. All started morning after receiving the vaccine & symptoms are just starting to improve as of 10/31/12.